Association of asymmetric dimethylarginine with acute pancreatitis-induced hyperglycemia

Pancreas

Volumn 45, Issue 5, 2016, Pages 694-699

  Trgo, Gorana ^a   Zaja, Ivan ^a   Bogut, Ante ^b   Vicic, Vesna Kovacic ^c   Meter, Ivana ^c   Lovrencic, Marijana Vucic ^a   Radman, Maja ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF MOSTAR   (Bosnia and Herzegovina)

^c University of Zagreb   (Croatia)

Author keywords

Acute pancreatitis; Asymmetric dimethylarginine; Diabetes mellitus; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; AMYLASE; C PEPTIDE; C REACTIVE PROTEIN; FRUCTOSAMINE; GLUCOSE; INSULIN; N(G),N(G) DIMETHYLARGININE; ORAL ANTIDIABETIC AGENT; RINGER LACTATE SOLUTION; TRIACYLGLYCEROL LIPASE; 3-NITROTYROSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; ARGININE; BIOLOGICAL MARKER; DEOXYGUANOSINE; ISOTONIC SOLUTION; N,N-DIMETHYLARGININE; RINGER'S LACTATE; TYROSINE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FLUID THERAPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LEUKOCYTE; MALE; NITROSATIVE STRESS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ACUTE DISEASE; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PANCREATITIS; PROCEDURES; SEVERITY OF ILLNESS INDEX; TIME FACTOR; URINE; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ARGININE; BIOMARKERS; DEOXYGUANOSINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUID THERAPY; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TYROSINE;

EID: 84944345731     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000516     Document Type: Article

References (33)

1. Lowenfels AB, Maisonneuve P, Sullivan T. The changing character of acute pancreatitis: Epidemiology, etiology, and prognosis. Curr Gastroenterol Rep. 2009;11:97-103.
2. Pavlidis TE, Pavlidis ET, Sakantamis AK. Advances in prognostic factors in acute pancreatitis: A mini-review. Hepatobiliary Pancreat Dis Int. 2010;9:482-486.
3. Das SL, Singh PP, Phillips AR, et al. Newly diagnosed diabetes mellitus after acute pancreatitis: A systematic review and meta-analysis. Gut. 2014;63:818-831.
4. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371: 143-152.
5. Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601-623.
6. Brookes PS, Yoon Y, Robotham JL, et al. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004;287: C817-C833.
7. Schulz HU, Niederau C, Klonowski-Stumpe H, et al. Oxidative stress in acute pancreatitis. Hepatogastroenterology. 1999;46:2736-2750.
8. Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness-update 2008. Crit Care. 2009;13:218.
9. Werner J, Rivera J, Fernandez-del Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery. 1997;121:23-30.
10. Al-Mufti RA, Williamson RC, Mathie RT. Increased nitric oxide activity in a rat model of acute pancreatitis. Gut. 1998;43:564-570.
11. Dayoub H, Achan V, Adimoolam S, et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation. 2003;108:3042-3047.
12. Valkonen VP, Päivä H, Salonen JT, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358:2127-2128.
13. Zoccali C, Bode-Böger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet. 2001;358:2113-2117.
14. Teerlink T. ADMA metabolism and clearance. Vasc Med. 2005; 10(suppl 1):S73-S81.
15. Anderssohn M, Schwedhelm E, Lüneburg N, et al. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diab Vasc Dis Res. 2010;7:105-118.
16. Teerlink T. Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clin Chem Lab Med. 2005;43:1130-1138.
17. Ceriello A, Mercuri F, Quagliaro L, et al. Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia. 2001;44: 834-838.
18. Wu LL, Chiou CC, Chang PY, et al. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339:1-9.
19. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102-111.
20. World Health Organisation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO; 2006.
21. Malecka-Panas E, Gasiorowska A, Kropiwnicka A, et al. Endocrine pancreatic function in patients after acute pancreatitis. Hepatogastroenterology. 2002;49:1707-1712.
22. Imamura T, Tanaka S, Yoshida H, et al. Significance of measurement of high-sensitivity C-reactive protein in acute pancreatitis. J Gastroenterol. 2002;37:935-938.
23. Kim YJ, Kim EH, Hahm KB. Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J Gastroenterol Hepatol. 2012;27:1004-1010.
24. Kylänpää ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol. 2010;16:2867-2872.
25. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm. 2010;2010:359732.
26. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27: 120-139.
27. Broedbaek K, Weimann A, Stovgaard ES, et al. Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic Biol Med. 2011;51:1473-1479.
28. Kurohane Kaneko Y, Ishikawa T. Dual role of nitric oxide in pancreatic β-cells. J Pharmacol Sci. 2013;123:295-300.
29. Ang AD, Adhikari S, Ng SW, et al. Expression of nitric oxide synthase isoforms and nitric oxide production in acute pancreatitis and associated lung injury. Pancreatology. 2009;9:150-159.
30. Calcerrada P, Peluffo G, Radi R. Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Curr Pharm Des. 2011;17: 3905-3932.
31. Zoccali C, Maas R, Cutrupi S, et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant. 2007;22:801-806.
32. Buchwalow I, Schnekenburger J, Tiemann K, et al. L-arginine-NO-cGMP signalling pathway in pancreatitis. Sci Rep. 2013;3:1899.
33. Ewald N, Hardt PD. Diagnosis and treatment of diabetesmellitus in chronic pancreatitis. World J Gastroenterol. 2013;19:7276-7281.